119 related articles for article (PubMed ID: 8639052)
1. Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study.
Blumenfeld W; Chandhoke DK; Sagerman P; Turi GK
Arch Pathol Lab Med; 1996 May; 120(5):478-81. PubMed ID: 8639052
[TBL] [Abstract][Full Text] [Related]
2. The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon.
Foley EF; Gaffey MJ; Frierson HF
Arch Pathol Lab Med; 1998 Oct; 122(10):912-4. PubMed ID: 9786353
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in human gastric carcinoma.
Waldum HL; Aase S; Kvetnoi I; Brenna E; Sandvik AK; Syversen U; Johnsen G; Vatten L; Polak JM
Cancer; 1998 Aug; 83(3):435-44. PubMed ID: 9690535
[TBL] [Abstract][Full Text] [Related]
4. Frequency and number of neuroendocrine tumor cells in prostate cancer: no difference between radical prostatectomy specimens from patients with and without neoadjuvant hormonal therapy.
Shimizu S; Kumagai J; Eishi Y; Uehara T; Kawakami S; Takizawa T; Koike M
Prostate; 2007 May; 67(6):645-52. PubMed ID: 17342745
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma.
Hamilton K; Chiappori A; Olson S; Sawyers J; Johnson D; Washington K
Mod Pathol; 2000 May; 13(5):475-81. PubMed ID: 10824917
[TBL] [Abstract][Full Text] [Related]
6. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions.
Fujii A; Kamiakito T; Takayashiki N; Fujii T; Tanaka A
Pathol Res Pract; 2003; 199(8):513-9. PubMed ID: 14533935
[TBL] [Abstract][Full Text] [Related]
8. Detection of neuroendocrine feature about salivary adenoid cystic carcinoma.
Sun C; Zhong M; Wang Z; Wang Y
Chin J Dent Res; 1999 Dec; 2(3-4):65-7. PubMed ID: 10863420
[TBL] [Abstract][Full Text] [Related]
9. Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma.
McKinney CD; Mills SE; Franquemont DW
Mod Pathol; 1995 May; 8(4):421-6. PubMed ID: 7567943
[TBL] [Abstract][Full Text] [Related]
10. Secretagogin is a novel marker for neuroendocrine differentiation.
Birkenkamp-Demtröder K; Wagner L; Brandt Sørensen F; Bording Astrup L; Gartner W; Scherübl H; Heine B; Christiansen P; Ørntoft TF
Neuroendocrinology; 2005; 82(2):121-38. PubMed ID: 16449819
[TBL] [Abstract][Full Text] [Related]
11. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
12. Secretagogin is a new neuroendocrine marker in the human prostate.
Adolf K; Wagner L; Bergh A; Stattin P; Ottosen P; Borre M; Birkenkamp-Demtröder K; Orntoft TF; Tørring N
Prostate; 2007 Apr; 67(5):472-84. PubMed ID: 17285592
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinicopathological significance of endocrine differentiation of gastric adenocarcinoma evaluated by double immunohistochemical labeling for chromogranin A and bromodeoxyuridine.
Hayashi H; Ooi A; Nakanishi I
Jpn J Clin Oncol; 1990 Dec; 20(4):339-48. PubMed ID: 1704442
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cox ME; Deeble PD; Lakhani S; Parsons SJ
Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
16. Do neuroendocrine cells, particularly the D-cell, play a role in the development of gastric stump cancer?
Waldum HL; Haugen OA; Brenna E
Cancer Detect Prev; 1994; 18(6):431-6. PubMed ID: 7867015
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation of periodic-acid Schiff and Alcian blue-negative signet-ring cell-like cells and tubular adenocarcinoma cells within a gastric cancer.
Sugihara A; Nakasho K; Yamada N; Nakagomi N; Tsujimura T; Terada N; Tsuji M
Scand J Gastroenterol; 2004 Aug; 39(8):795-800. PubMed ID: 15513370
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry of synapsin I and synaptophysin in human nervous system and neuroendocrine tumors. Applications in diagnostic neuro-oncology.
Smith TW; Nikulasson S; De Girolami U; De Gennaro LJ
Clin Neuropathol; 1993; 12(6):335-42. PubMed ID: 8287627
[TBL] [Abstract][Full Text] [Related]
19. Chromogranin A expression in human colonic adenocarcinoma.
Romeo R; Pellitteri R; Mazzone V; Marcello MF
Ital J Anat Embryol; 2002; 107(3):177-83. PubMed ID: 12437144
[TBL] [Abstract][Full Text] [Related]
20. Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin.
Sentani K; Oue N; Noguchi T; Sakamoto N; Matsusaki K; Yasui W
Pathol Int; 2010 Apr; 60(4):291-7. PubMed ID: 20403031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
